The predominant manifestation of Leber hereditary optic neuropathy (LHON) is a sudden and usually severe bilateral loss of central vision, most often in the mid-20s, that is due to a degeneration of the ganglion cell layer and optic nerve. LHON is an inherited form of blindness in which a mutation in the mitochondrial genome (mtDNA) is the primary etiological event. More than 95 % of the LHON pedigrees in peoples of Northern European descent harbor one of the three mitochondrial mutations at nucleotides 3460, 11778 and 14484, although there are other l~are primary mutations. In addition, there may be mtDNA mutations that have a secondary etiological role. The penetrance of the optic neuropathy is incomplete in LHON families, and males are affected much more often then females. The incomplete penetrance indicates that secondary etiological factors are necessary for the development of the optic neuropathy, although they are poorly understood at the present time. Several types of studies suggest that optic nerve function in LHON patients is impaired in the presymptomatic phase, probably as a result of a mitochondrial respiratory chain abnormality, although visual acuity is not compromised. In some family members, the presence of secondary etiological factors triggers a wave of optic nerve dysfunctien in which vision is lost (the acute phase). Depending upon the particular primary LHON mutation that the patient carries, a variable proportion of the dysfunctional ganglion cells and optic nerve axons die during the atrophic phase, probably through an apoptotic pathway. In 11778 LHON patients, retinal ganglion cell degeneration occurs almost without exception, and recovery of vision is extremely rare. In contrast, activation of the cell death pathway is less frequent, or less extensive, in 14484 LHON patients and there is often a substantial recovery of vision.
INTRODUCTION
In 1871, Theodor Leber published the first detailed description of an inherited form of blindness that has been eponymously designated Leber hereditary optic neuropathy (LHON). LHON is most generally described as a bilateral, acute, or sub-acute, loss of central vision in otherwise healthy young adults, predominately males. It was first observed by Leber, and subsequently confirmed in numerous studies (Bell, 1931; Lundsgard, 1944; van Senus, 1963; Seedorff, 1970; Nikoskelainen et al., 1987; Mackey & Buttery, 1992) , that the risk of vision loss in LHON families is inherited exclusively from the mother, irrespective of whether or not she is visually affected. It is now recognized that this pattern of maternal inheritance indicates that the primary etiologic event in LHON is a mutation within the mitochondrial genome, the small *Biology Division F-56, Department of Radiation Therapy, Department of Human Biological Chemistry and Genetics, The University of Texas Medical Branch, Galveston, TX 77555-0656, U.S.A.
DNA molecule (<17000 basepairs) that encodes 13 protein subunits of the respiratory chairL complexes (Anderson et al., 1981) . A number of mitochondrial genetic diseases have been identified during the last few years, LHON being the most prevalent, most of which are associated with neurological abnormalities [reviewed in Johns (1995) ; Wallace (1995) ].
A second interesting feature of LHON is the specificity of its neuropathology. The loss of vision in LHON patients is due to the specific degeneration of the ganglion cell layer and the optic nerve; this focal pathology occurs despite the systemic presence of the mutation. The simple story, therefore, is that mitochondrial mutations can lead to optic nerve degeneration. This causal relationship is not surprising because of the high energy demands of the visual system and the key role of mitochondria in cellular energy production. It is emerging, however, that LHON is both more complex and more interesting than this simple story. The purpose of this review i~,; not only to summarize the genetic, biochemical, pathological, and 3495 3496 N. HOWELL clinical studies that have been carried out on LHON patients, but also to discuss how systemic mitochondrial mutations might cause a focal neurodegeneration. Furthermore, emphasis is given to the similarities between LHON and other optic nerve degenerative disorders.
PATHOGENIC MITOCHONDRIAL MUTATIONS IN

LHON PATIENTS
The identification of the mitochondrial gene mutations that are the primary causative factors in LHON has not been as straightforward as one might anticipate, given the plethora of well-documented LHON families and the small size of the mitochondrial genome Howell, 1994a, b) . There are several factors that have complicated the identification of pathogenic mutations in LHON patients:
1. the rapid evolution of the mitochondrial genome results in extensive divergence so that, typically, pathogenic mutations are "hidden" within a background of multiple sequence changes; 2. the analysis of singleton cases and/or small families with bilateral optic atrophy raises the possibility that these are not "true" (viz. mitochondrial) LHON patients; 3. similarly, families have been analyzed that have a LHON-like optic neuropathy and additional neurological abnormalities; and 4. the presence of mitochondrial mutations that may have a secondary etiological role.
The mitochondrial genomes from numerous LHON families and patients have now been analyzed. One view is that there are many mitochondrial mutations, affecting different respiratory chain complexes, that have a primary or secondary pathogenic role. Thus, Brown and Wallace (1994) list 16 mitochondrial mutations associated with LHON (their Table 1 ). In opposition to this view, there is impressive evidence that the vast majority of LHON families carry one of only three primary pathogenic mutations, these occurring at nucleotides 3460, 11 778, and 14484. These mutations result in amino acid substitutions in the ND1, ND4, and ND6 genes, respectively, which are three of the seven mitochondrial genes that encode subunits of complex I of the respiratory chain (NADH-ubiquinone oxidoreductase). As an example of this more conservative approach, David Mackey (Melbourne University) has been spearheading a large collaborative effort to identify the primary pathogenic mitochondrial mutations in LHON patients and their population frequencies. Analysis has been limited to families with the "classical" optic neuropathy (viz. not accompanied by additional neurological or pathological abnormalities) and to those with multiple affected members in different generations, which should eliminate autosomal recessive or dominant optic atrophies. With these exclusion criteria, 159 LHON families (totaling over 11 000 members, >1500 of whom have been affected visually) from Northern Europe, the United Kingdom, and Australia were analyzed . It was found that 153 families (96%) carried either the 3460 (21 families), the 11 778 (110 families), or the 14 484 (23 families) primary LHON mutation. Both Johns (1995) and Wallace (1995) continue to vouchsafe a pathogenic role for a mutation at nucleotide 15 257 that alters an amino acid residue of the protonmotive cytochrome b subunit of complex III (see the discussion in Howell, 1994a, b) . However, none of the LHON families in this large survey carried the 1:5 257 mutation in isolation of one of the three primary mutations. At the present time, therefore, it appears that the spectrum of primary LHON mutations may be narrow and that several of the putative primary mutations that were identified previously should be viewed with skepticism pending further analysis (Howell, 1994a, b) . Although additional, rare primary LHON mutations will probably be identified [e.g. Howell et al. (1993b) ], their significance should be "weighted" appropriately. Furthermore, and this may be a key point for pathophysiology, LHON may be caused only by mitochondrial mutations that affect complex I. Johns and Berman (1991) were the first investigators to propose that, in addition to primary mutations, there might be mitochondrial mutations that play a secondary role in the etiology and/or pathogenesis of LHON. In contrast to primary mutations, secondary mutations are found in normal controls, but at a lower frequency than in LHON patients. Additionally, they tend to produce more conservative amino acid changes and/or in less stringently conserved residues. Among Australian 11 778 LHON families, the penetrance of the optic neuropathy was higher in those whose mitochondrial genomes carry secondary LHON mutations than in those who do not ] Howell et al, (1993a) ; see also Johns (1994) ]. This comparative approach is fraught with simplifying assumptions, however, and other studies have not supported a pathogenic effect of secondary mutations (Oostra et al., 1994; Nikoskelainen et al., 1996) . Furthermore, we have recently shown that the increased frequency of secondary mutations in LHON patients can be explained solely in terms of population history and genetics LHON mutations, and they may be benign polymorphisms. It is one thing for mitochondrial geneticists to debate the pathogenic role of a putative LHON mutation, but where does this uncertainty leave clinicians when diagnosing patients with suspected LHON, and when counseling affected and unaffected family members? If a patient carries one of the three "canonical" mutations (at nucleotides 3460, 11 778, or 14484), of if there is a definite pattern of maternal inheritance but no identified mutation, then counseling is fairly straightforward. On the other hand, if maternal inheritance is dubious or uncertain, and/or if a rare, noncanonical LHON mutation has been found, then counseling and diagnosis should reflect the uncertainty attached to such mutations.
THE OPTIC NEUROPATHY IN LHON AND
RECOVERY OF VISION
The initial symptom during the acute phase of LHON (summarized in Fig. 1 ) is a blurring or clouding of vision in one eye, and then the other, that progresses, usually without pain, over a period of weeks to its nadir. The initial field defect is an enlargement of the blindspot that expands to an absolute central or cecocentral scotoma, often breaking through at the periphery. Dyschromatopsia is invariably present and it may be the earliest indicator of optic nerve dysfunction (Miller, 1982) . In approximately one half of those affected, both eyes are affected simultaneously although a delay of weeks or months is also common. Loss of visual acuity is typically severe and complete blindness can occur; one study, for example, found that the median final visual acuities were 1/60 and 3/60 in LHON patients with the 11 778 and 3460 primary mutations, respectively . Males and females appear to be affected to similar extents although affected women with the 11778 mutation may have a more severe loss of vision . The mean age of onset, for both sexes, is in the mid-twenties but the: range is remarkably broad, ranging from children under the age of 10 yr to adults in their seventies. There is no discernable correlation among age of onset, the time to nadir, or extent of vision loss for patients with the 11 778 or 3460 primary LHON mutations. The situation with regard to the 14484 mutation is more complicated and it will discussed further below. There are also LHON patients in which there is an atypical optical neuropathy including a slowly progressive presentation [e.g. Weiner et al. (1993) ; Swartz & Savino (1994); Nikoskelainen et al. (1996) ]. A number of excellent reviews of the optic neuropathy in LHON patients have appeared in recent years and they should be consulted for details [e.g. Miller (1982) ; Newman et al. (1991); Johns (1994) ; Nikoskelainen (1994) ; Sherman & Kleiner (1994) ; Riordan-Eva et al. (1995); Nikoskelainen et al. (1996) ].
One of the most peculiar clinical features of LHON is the preservation of pupillary responses, even in those patients who have severe loss of central vision (Sherman & Kleiner, 1994; Nikoskelainen et al., 1996) . Videopupillographic analysis by Wakakura and Yokoe (1995) of 12 patients with the 11 778 primary mutation and of one with the 14 484 primary mutation demonstrated that the pupillary responses were more intact than those measured in patients with idiopathic optic neuropathy or anterior ischaemic optic neuropathy, suggesting a preferential sparing of the W ganglion cells in LHON patients.
Extensive fundoscopic data are available for presymptomatic or unaffected family members, and for affected individuals in the acute and atrophic phases [in particular, see Nikoskelainen (1994) ; Riordan-Eva et al. (1995) ]. Particular attention has been paid to a peripapillary microangiopathy that was first described by Leber (1871) and that involves tortuous vessels in the central retina and telangiectatic capillaries. The microangiopathy is present in presymptomatic individuals and during the acute phase, where it is often more marked because of the dilation of the vessels and arteriovenous shunting, but it resolves during the atrophic phase. Fluorescein angiography has shown that "leakage" from these tortuous vessels and retinal hemorrhages are rare (viz. the vascular endothelium is not compromised). Nikoskelainen (1994) asserts that dilation of the microangiopathic vessels signals imminent commencement of the acute phase and she has proposed that LHON is primarily an intraocular microvascular disorder. However, there is controversy over such a primary pathophysiological role for the microangiopathy (Newman et al., 1991; .
Another early change during the acute phase is a pseudoedema of the nerve fiber layer and apparent hyperemia of the disk (van Senus, 1963; Nikoskelainen, 1994) . During the atrophic phase, the disk becomes pale; the peripapillary nerve fiber layer disappears, initially in the papillomacular bundle and then outside of this region. Miller (1982) has noted abnormality in the peripapillary nerve fiber layer in asymptomatic LHON family members but it was not ascertained if these individuals subsequently became visually affected.
Vision loss in LHON patients is usually permanent, but a significant proportion of patients show objective improvement, sometimes to a dramatic degree. Recovery in 11 778 patients is rare; Johns (1994) , for example, cites a frequency of 4%. In marked contrast, approximately one-half of all 14 484 LHON patients show improvement. Furthermore, the frequency of improvement is particularly high in those patients who lose vision before the age of 30 yr [reviewed in Mackey & Howell (1992) ; Johns (1994) ; Riordan-Eva et al. (1995) ]. Recovery of vision in 3460 LHON patients appears to have an intermediate frequency (Johns, 1994) . There may be a further difference between 11778 and 14484 LHON patients. Recovery in the former often involves a small island of vision whereas there is noticeable shrinkage of the field defect in 14484 patients (Mackey & Howell, 1992; Hrynchak & Spaflord, 1994) . Finally, recovery of vision may occur relatively soon after vision loss, or it may not be noticeable for several years. The recovery of vision in LHON patients indicates that this disorder cannot involve an all-or-nothing neurodegeneration; instead, at least in a large proportion of 14484 LHON patients, there are ganglion cells that reversibly lose function but avoid the cell death process for months or years.
In addition to the optic neuropathy, there are numerous LHON family members in which there are also nonophthalmological abnormalities including peripheral neuropathy, CNS signs, and heart conduction defects [e.g. Newman et al. (1991); Nikoskelainen et al. (1995) ; Riordan-Eva et al. (1995) ], a phenomenon that was first described by Leber (1871) . In addition, LHON family members, usually females, reportedly have an increased risk of developing an MS-like condition (Flanigan & Johns, 1993; Riordan-Eva et al., 1995; Jansen et al., 1996) . These extra-ophthalmological abnormalities suggest that the neuropathology in LHON may be more diffuse and more varied than generally realized. At the present time, however, there is little else that can be noted other than their occurrence.
An important exception to this general or "core" pattern is a group of families in which there is maternal inheritance of both a LHON-like optic neuropathy and relatively severe neurological abnormalities. For example, Wallace and coworkers have studied a "LHON plus dystonia" family in which a mutation at nucleotide 14459 causes the disorder (Wallace, 1995) . The proximity of this mutation to the primary LHON mutation at nucleotide 14484 is striking. The QLD1 LHON family, in which there is also an array of severe neurological abnormalities (Wallace, 1970) , is another example, but the etiology is different. In this family, the results indicate that the ophthalmological deficits are caused by the 14 484 primary LHON mutation whereas the neurological abnormalities appear to be caused by a second pathogenic mutation at nucleotide 4160 of the NDI gene (Howell, 1994a ). De Vries et al. (1996 have recently suggested that mutations at nucleotides 11 696 and 14596 are associated with a Dutch matrilineal pedigree in which LHON is combined with spastic dystonia.
ELECTROPHYSIOLOGICAL TESTS IN LHON PATIENTS
Electrophysiological studies of LHON patients have been comprehensively reviewed by Sherman and Kleiner (1994) and only a brief summary is presented here. There is general agreement that flash electroretinograms (ERG) and electrooculograms (EOG) are normal in LHON patients, indicating functional integrity of the photoreceptors, bipolar cell layer, and retinal pigment epithelium. Riordan-Eva et al. (1995) reported that 3 of 34 LHON patients had reduced "b" waves in their flash ERGs, perhaps representing retrograde transneuronal degeneration of preganglionic elements [see also ]. Integrity of visual evoked potentials (VEPs), which report the functional status of the maculus at the level of the occipital cortex, is a more complex issue. During the early acute phase, the VEPs become desynschronized, the amplitudes are decreased, and the latencies are prolonged. At the atrophic stage, it is generally observed that the VEPs are extinguished, which is expected because of the loss of ganglion cell function. However, there is conflicting evidence surrounding the timing of VEP abnormalities: some inw~stigators have reported alterations in asymptomatic LHON family members whereas others conclude that the VEP abnormalities are synchronous with the loss of vi~sual acuity.
Another test is the critical frequency of' photic driving (CFPD), the electrophysiological counterpart of the critical flicker fusion, which measures the highest frequency of photic driving to repetitive flash stimulation [discussed in Sherman & Kleiner (1994) ]. CFPD frequencies are decreased in patients with demyelinating disorders but they were reported to be normal in one 14 484 LHON patient, despite the presence of abnormal VEPs (Kothe et al., 1990) . It is possible that normal CFPDs will be found in other LHON patients. However, it must be kept in mind that this patient's visual acuity loss was not severe, and that it subsequently showed marked improvement (Hrynchak & Spafford, 1994) . There is a clear need for longitudinal electrophysiological testing of both affected and unaffected LHON family members to resolve these issues and to obtain information about the relative impairment of the magno (M) and parvo (P) pathways (Sherman & Kleiner, 1994) .
THE NEUROPATHOLOGY OF LHON
In view of the interest in LHON, and its prevalence, it is surprising that there have been so few neuropathological studies. Furthermore, those studies that have been carded out have been seriously limited by two constraints. In the first place, most of them involved patients in which the primary LHON mutation was not identified although a positive history of maternal transmission was noted in some cases. Moreover, there has been a tendency, perhaps unintentional, to study patients with accompanying neurological abnormalitie:~ [e.g. Kwittken & Barest (1958) ; Wilson (1963) ], thereby raising the possibility that the findings do not reflect those to be found in more typical LHON patients. Secondly, neuropathological studies have been carried with patients who lost vision many years prior to death. Because there is no "hard" information about the kinetics of neurodegeneration in LHON (see also the next section), it may be risky to extrapolate the neuropathology at autopsy to that at the time of the acute phase. For example, the acute phase may signal the only (or major) wave or burst of optic nerve degeneration; in this case, the final neuropathological status would be indicative of that at the beginning of the atrophic phase. On the other hand, the acute phase may only signal that crucial point in a long period of neurodegeneration when visual system failure was manifested. The tbrmer possibility seems the more likely because there is no trend for vision loss to progress during the atrophic phase. However, the recovery of vision in 14484 LHON patients is a salutary reminder that we must distinguish loss of vision from optic nerve degeneration.
These limitations notwithstanding, the neuropathological studies have consistently shown a degeneration of the ganglion cell layer and of the optic nerve without any signs of an inflammatory process. For example, Kwittken and Barest (1958) have published what is probably the most complete pathological study of a putative LHON patient. This patient died of congestive heart failure 40 yr after losing vision at the age of 17 yr: with reference to the preceding discussion, it was remarked that his pupillary responses were still intact prior to death. The ganglion cell layer and optic nerve were atrophic with some degeneration in the inner nuclear layer. There was some excavation of the disk, with glial and connective tissue filling, and there was also marked thickening of the glial septa in the optic nerve. Examination of the optic nerves, optic chiasm, and optic tracts revealed that axonal degeneration and demyelination occurred preferentially in the central regions, a finding that they noted was compatible with the loss of central vision. Furthermore, there was marked anterograde transneuronal degeneration in all six layers of the lateral geniculate bodies. This latter finding is particularly noteworthy because it argues against the suggestion that LHON involves preferential loss of the P ganglion cells (Rizzo, 1995) .
Finally, these investigators observed demyelination and gliosis in the gracilis columns of the spinal cord as well as some demyelination in the peripheral nerves of the lower extremities. They concluded that the peripheral neuropathy was unrelated to the optic neuropathy but, instead, was due to the patient's "malnutrition" (skeletal abnormalities were also present). However, the presence of peripheral neuropathy and skeletal abnonnalities in other LHON patients (see above) suggests that future neuropathological studies should further explore this issue.
A genetically unconfirmed, singleton LHON case was described by de Gottrau et al. (1992) . They noted atrophy of the ganglion cell layer and nerve fiber layer whereas the outer retinal layers were normal. The optic nerve, chiasma, optic tracts, and lateral geniculate nuclei were atrophic, more severely so in those regions connecting to the macular fibers. Furthermore, the dura mater and arachnoid of the optic nerve were markedly distended with considerable widening of the subarachnoid space. There are also CT and/or MRI findings of optic nerve distension in LHON patients (including some who carry the 11 778 primary mutation), sometimes appearing soon after the onset of the acute phase (Kermode et al., 1989; Smith et al., 1990) . The usual interpretation of the distension is gliosis and/or edema: Wilson and Kline (1992) reported similar findings and the release of CSF during decompressive surgery. reported the first neuropathological study of a genetically confirmed LHON patient: she carried the 11 778 primary mutation and she had suffered a rapid decline in vision to light projection 30 yr prior to death. The typical losses of the ganglion cell layer and nerve fiber layer were noted but there was also a mild loss of photoreceptors. There was no evidence for a marked inflammatory reaction and the histopathology was clearly different from that seen in MS-associated optic neuritis. It was particularly striking that there was an overall loss of 95% of the axons in the optic nerve with some sparing in the naso-dorsal periphery. Furthermore, because the prechiasmal axon count was higher than that in the optic tract, they concluded that there may have been selective sparing of the optic nerve fibers that project to the perichiasmal structures. Such a pattern might explain retention of pupillary responses in affected LHON patients, but it raises the question of why these fibers are more resistant to neurodegeneration in LHON. Finally, these authors suggest that the abundance of debris in the optic nerve may represent the sequelae of a failure in axoplasmic transport.
Finally, Kerrison et al. (1995) have recently published the neuropathology of a patient from the QLD 1 LHON family (see above), a woman who died at the age of 81 yr. There was the typical pattern of atrophy of the nerve fiber and ganglion cell layers without signs of inflammation. Within the optic nerve, there was a diffuse alxophy of the nerve fiber bundles, gliosis, demyelination, and thickening of the pial septae. In contrast to some of the other studies, there was no marked sparing of fibers in the periphery of the optic nerve. Electron microscopy (EM) revealed that the remaining ganglion cells were swollen and contained both swollen mitochondria and doublemembrane enclosed inclusions that had a high calcium content. The authors speculated that the calcium deposits may be related to an excitotoxic pathway of neurodegeneration. Calcium deposits, or calcified nfitochondria, have not been reported in other studies of LHON patients, but this may simply reflect the paucity of EM studies. Alternatively, these findings may indicate that markedly abnormal calcium transport (and excitotoxicity) was causally associated with the 4160 mutation, rather than with the 14484 LHON mutation, although the histopathology of the retina and optic nerve was typical of LHON.
RESPIRATORY CHAIN FUNCTION IN LHON PATIENTS AND THE BIOENERGETICS OF VISION
The extent and nature of mitochondrial respiratory chain dysfunction in LHON patients is another controversial topic. Evidence for respiratory chain dysfunction in 11 778 LHON patients has recently been obtained by Montagna et al. (1995) with 31P-NMR spectroscopy and serum lactate assays. However, biochemical assays of isolated mitochondria have yielded results that are more ambiguous. For example, Larsson et al. (1991) found no decrease in complex I specific activity (or in any other complex) in mitochondria isolated from affected and unaffected members of an 11 778 LHON family. However, when flux through the entire chain was assayed by measuring the rate of oxygen uptake with NADHlinked substrates, the rate was decreased to about onehalf of that found in mitochondria from not:alal controls. In contrast, there was no decrease in flux with succinate as substrate, which enters the respiratory chain through *Lactate and pyruvate release were measured after an incubation period of 6 hr. The experimental conditions were as follows: fibroblasts were plated at a density of ca 1.5 × 106 cells/10 cm petri dish in MEM medium (13% fetal calf serum). After an overnight incubation, the medium was aspirated, the dishes were rinsed once with medium, and then fresh medium was added. Rotenone was added to a final concentration of 1.0 #g/ml. tMean ___ 95% C.I. (number of assays).
complex II. The authors concluded that the respiratory chain defect may lie in the interactions of the dehydrogenases with complex I, rather than in electron transfer through the complex. Essentially the same results were obtained by Majander et al. (1991) in studies with EB-virus transformed lymphocytes. We have also confirmed that there is no decrease in complex I specific activity in mitochondria from the WBC/platelet fraction of whole blood samples from 11 778 LHON patients (Bindoff et al., manuscript in preparation). Smith et al. (1994) detected a small decrease (25%) in platelet mitochondrial complex I specific activity when nonsmoking 11778 LHON patients were compared to nonsmoking controls, but no difference was found when smokers were included. Degli Esposti et al. (1994) have suggested that the 11 778 mutation reduces the "affinity of complex I for the ubiquinone substrate and increases resistance to rotenone, a complex I inhibitor that probably functions as a quinone analog. Their interesting findings need confirmation.
The recent work of Vergani et al. (1995) points the way to a potentially more powerful experimental approach. They constructed cybrid lines in which mitochondria from control or 11 778 LHON patients, were transferred to cells that lack their own mtDNA (designated rho-zero lines). The 11778 primary LHON mutation caused decreased cellular respiration and lower mitochondrial complex I specific activity although the latter decrease was not statistically significant. Furthermore, they found that the presence of two secondary LHON mutations exacerbated the respiratory chain dysfunction.
The results for the 3460 primary mutation have, thus far, been more clear-cut. In our initial studies (Howell et al., 1991) , platelet mitochondria were isolated from both affected and unaffected 3460 LHON family members.
When specific activities of the respiratory chain complexes were normalized to the specific activity of citrate synthase, another mitochondrially-locafized enzyme, there was an ca 80% reduction in complex I specific activity whereas there was no reduction in those of complex II or complex IV (cytochrome oxidase). Similar marked reductions were obtained in the studies of Majander et al. (1991) and of Smith et al. (1994) . It is noteworthy that the complex I dysfunction was similarly severe in both affected and unaffected LHON family members, and in both males and females: this finding supports the inference from incomplete penetrance that the primary mutation is necessary--but insufficient--for the optic neuropathy.
The effect of the 14 484 primary LHON mutation upon respiratory chain function has been particularly problematic. Parker et al. (1989) measured an ca 80% reduction in complex I specific activity in platelet mitochondria from QLD1 LHON patients; there were milder decreases in the activities of complexes II1 and IV, but these were not statistically significant. The interpretation of these results is complicated by the simultaneous presence of the 14 484 LHON and 4160 mutations. Cock et al. (1995) found no respiratory chain dysfunction in fibroblast mitochondria from 14 484 "only" LHON patients. Our preliminary results, however, indicate a marked complex I defect in 14 484 fibroblast mitochondria (Bindoff et al., manuscript in preparation). Furthermore;, Oostra et al. (1995) , in assays with mitochondria from leucocytes of 14484 LHON patients, also obtained evidence for a respiratory chain defect. They observed that complex I specific activity was reduced >50% when normalized to the level of citrate synthase or to complex IV but complex I-driven ATP synthesis was reduced only 20%.
Our laboratory has taken a different tack to this problem. There are a number of technical problems that ensnare the unwary when one attempts to isolate mitochondria and to then assay re,;piratory chain functions. In an effort to avoid these pitfalls, we have chosen to measure the release of lactate and pyruvate from intact, dividing fibroblasts. The lactate:pyruvate ratio is a sensitive indicator of the NADH/NAD balance and it will, in large part, be "set" physiologically by flux through the mitochondrial respiratory chain. When the respiratory chain is blocked, the NADH generated by the citric acid cycle and glycolysis accumulates and the lactate:pyruvate ratio increases. This approach has already been applied to fibroblasts from 11 778 LHON patients (Cornelissen et al., 1993) , but the results were equivocal: increased ratios were found for some patients, but not for others. Their experiments seem to suffer from rather large variabilities and we have observed that the lactate:pyruvate ratio is exquisitely sensitive to the cell culture and incubation conditions (Howell et al., manuscript in preparation). Nevertheless, we have been able to obtain reasonable experimental variabilities and a sample of our results is shown in Table 1 . These data indicate that there is a partial respiratory chain impairment, under these experimental conditions, as a consequence of the 3460, 11 778, and 14 484 primary LHON mutations.
It is explicit in the OXPHOS (Wallace, 1995) and the ATP deficiency (Rizzo, 1995) hypotheses that LHON involves neurodegeneration of those cells (viz. retinal ganglion cells) that have the highest demand for mitochondrially-produced energy. One must treat these hypotheses with caution, however, because previous studies of the bioenergetics of vision do not indicate that ganglion cell function is markedly dependent upon mitochondrial energy production. In fact, it has been recognized for 40 yr that the photoreceptor layer of the retina is the richest in its content of the enzymes for oxidative metabolism (Lowry et al., 1956) . In an elegant series of experiments, Ames et al. (1992) showed that phototransduction was supported by oxidative energy (generated by the mitochondria) whereas neurotransmission through the inner retina was fueled almost exclusively by glycolysis. These investigators also found that about one-half of the oxidative energy was consumed in processes that could not be identified although the active transport of calcium is one untested possibility. However, the studies of Ames et al. were relatively shortterm and it may be that long-term viability or function of the ganglion cells has a high requirement for nfitochondrially-produced energy. In this regard, axoplasmic transport has such a requirement [Ochs (1971) ; see also Hollander et al. (1995) ]. Also, mitochondrial function is necessary to regenerate NAD from NADH; in other words, normal mitochondrial function may be necessary for maintaining the proper redox balance in the ganglion cells, rather than for ATP biosynthesis per se. In this context, the fact that primary LHON mutations affect complex I subunits, and that this complex is the site of NADH reoxidation, appears much more than coincidental. Finally, we must introduce the possible role of excitotoxicity, more of which is discussed in the subsequent sections. A number of studies have shown that reduced mitochondrial energy production leads to an activation of the NMDA-type glutamate receptors through relief of the voltage-dependent magnesium block [reviewed by Ludolph et al. (1993); Beal (1995) ]. When the block is relieved, there is increased ion transport (particularly calcium) into the cells, ultimately resulting in cell death.
INCOMPLETE PENETRANCE AND RISK FACTORS FOR MANIFEST BLINDNESS
A feature of LHON that complicated early studies of its inheritance was its incomplete penetrance. Historically, it has been observed in large European LHON families that ca 50% of the males and 10% of the females developed the optic neuropathy (Bell, 1931; Lundsgard, 1944; van Senus, 1963; Seedorff, 1970; Nikoskelainen et al., 1987 patients, the penetrances are 39% (males)/14% (females) and 32% (males)/15% (females) for the 11 778 and 3460 primary mutations, respectively [Nikoskelainen (1994) , but see Black et al. (1995) ].
The most important conclusion that has been drawn from incomplete penetrance is that the primary mutation is the major risk factor in LHON but that additional etiological factors are necessary. A great deal of effort has been expended to unravel the complex etiology of LHON, and several possible factors have been identified. In most LHON patients, the primary mutation is homoplasmic; that is, every mtDNA molecule carries the mutant allele. However, in a small proportion of LHON patients (ca 15%), the primary mutation is heteroplasmic and there are two populations of mitochondrial DNA molecules, one carrying the wildtype allele and the other carrying the mutant allele [e.g. Smith et al. (1993); Ghosh et al. (1996) ]. What can be safely asserted is that heteroplasmy of the primary mutation is not a major factor because there are large, wellcharacterized LHON families in which the primary mutation is homoplasmic and penetrance is incomplete.
The marked disparity in penetrance between males and females within LHON families suggests an X-linked susceptibility locus that modifies pathophysiology. The initial experimental (Vilkki et al., 1991) and theoretical studies (Bu & Rotter, 1991) supported this possibility. More recent studies, however, have failed to locate such a locus (Carvalho et al., 1992; Sweeney et al., 1992; Juvonen et al., 1993; Mackey, 1993; Pegoraro et al., 1996) . Interest in this hypothesis continues as recently concluded that, within their LHON families, affected females had a higher incidence of affected offspring than did unaffected females. Resolu-tion of this question may require separate analysis of LHON pedigrees according to primary mutation (Black et al., 1995) . Alternatively, there may not be a single Xlinked susceptibility locus and the disparity in penetrance may be polygenic in origin or due to diffuse physiological and/or anatomical differences between males and females.
There is considerable evidence that heavy alcohol and/ or tobacco use increases the risk of the optic neuropathy in LHON family members (Johns, 1994; . LHON family members have also lost vision shortly after head trauma (D. Mackey, personal communication) or after extreme physical exertion (J. Sherman, personal communication). There is also the striking report of a young girl who carried the 11 778 primary mutation (DuBois & Feldon, 1992) . At 9 yr of age, she simultaneously developed juvenile onset diabetes mellitis and optic neuropathy. Once her diabetes was controlled with insulin, her optic neuropathy improved. On the other hand, there are many LHON patients for whom no precipitating incident or chronic stress can be discerned. One of the difficulties in "pinning down" risk factors is that it is not clear when such factors may operate. Does one limit consideration only to those events or conditions that occur within a few weeks prior to the onset of vision loss? A more complete and rigorous epidemiological analysis of LHON would provide much-needed information.
Another complicating factor in this area is that the overall penetrance in Australian LHON families has decreased in recent generations (Mackey & Howell, 1994) . The incidence of affected males and females has decreased to about 20% and 4%, respectively (see also Table 3 of Harding et al., 1995) , a trend that may reflect reduced environmental or dietary risk factors.
These are uncharted waters, but some summarizing speculation may stimulate further theoretical consideration and experimental analysis. There are two general models for the development of the optic neuropathy, which we may term the "threshold" and the "trigger" models (Fig. 2) . In the first, there is a continuous rate of ganglion cell degeneration that is the cumulative product of several factors. In individuals who carry a primary LHON mutation, the rate of neurodegeneration would be increased and additional environmental and lifestyle, genetic, and physiological (including normal aging) factors would further modify the rate. Once the extent of neurodegeneration exceeds a certain threshold, then the acute phase is initiated. The threshold model for mitochondrial diseases, including LHON, has been most persuasively argued by Wallace and coworkers [e.g. Brown et al. (1992) ; Wallace (1995) ]. Alternatively, the primary LHON mutation may impair ganglion cell metabolism without producing substantially increased neuronal death. However, additional insults or conditions in these at-risk, more susceptible individuals would then "trigger" a wave of neurodegeneration. The trigger model seems more compatible with the available data. Burde (1993) has recently developed the "disk at risk" concept in which he identifies some anatomical features that are common to several optic neuropathies including:
THE DISK-AT-RISK AND LHON
1. LHON; 2. nonarteritic anterior ischemic optic neuropathy; 3. anterior ischemic optic neuropathy of the young; and 4. the papillopathy in patients with juvenile-onset insulin-dependent diabetes mellitis.
He does not include the toxic amblyopias, but in view of the evidence cited below, they would seem to be additional members of this group of optic nerve disorders. The anatomical features that characterize the "disk at risk" are a relatively small optic nerve head, absent or small cup, increased branching of the central retinal vessels within the disk, and a crowding or "heaping up" of the nerve fiber layer. He further postulates that the region in and around the lamina cribosa is particularly vulnerable to ischemia because vascularization is limited to the end arteries of the posterior ciliary circulation or the circumferential vessels of the circle of Zinn Haller.
Burde envisages that these anatomical features lead to the optic neuropathy in LHON patients because the respiratory chain defect produces axoplasmic stasis and swelling, which in turn leads to further ,compression of the vessels and nerve fibers in this region, which then produces a more severe ischemia, ultimately causing an acute and major episode of neurodegene.ration. In their discussion of this concept, suggested another anatomical feature that contributes to the susceptibility of the optic disk. They point out that the axons of the optic nerve are sharply bent as they enter the laminosa cribosa and that there may be a higher energy demand for axoplasmic transport in this :region. Furthermore, the septae of the lamina cribosa are more closely packed and thicker walled along the horizontal meridian of the optic nerve, which are the areas that "channel" the fibers that subserve the central and temporal portion of the visual field, the regions that are most commonly and most severely affected in LHON (Fechtner & Weinreb, 1994) . There is one final piece of anatomical evidence that supports the "disk at risk" concept and, particularly. its role as a factor in LHON. Electron microscopy of the: optic nerve reveals that there is a prominent accumulation of mitochondria (and other organelles) in the unmyelinated lengths of the prelamellar optic nerve axons as they transverse the lamina cribosa that may demarcate a zone of impaired or labile axoplasmic transport (Minckler et al., 1976; Hollander et al., 1995) .
Taken together, these results suggest that the optic disk and the optic nerve transversing the lamina cribosa are regions that might be particularly vulnerable, a "chokepoint", to the consequences of mitochondrial dysfunction. The prominent and early involvement of the papillomacular bundle during the acute phase, discussed previously, also supports this hypothesis',.
LHON AND OTHER BILATERAL OPTIC NEUROPATHIES
In terms of the ophthalmological presentation, LHON is one of a group of bilateral optic neuropathies that includes the toxic amblyopias (also designated tobaccoalcohol or nutritional amblyopia). Adult-onset bilateral optic neuropathy is a relatively common problem, but the etiology remains to be identified in most cases, even when reasonable efforts are taken to exclude LHON and MS [e.g. Morrissey et al. (1995) ; Chan et al. (1996) ].
Tobacco-alcohol amblyopia
LHON is frequently misdiagnosed as tobacco alcohol amblyopia [e.g. Cullom et al. (1993) ]. Furthermore, there is a parallel decline in penetrance of the optic neuropathy in Australian LHON families and in the incidence of tobacco-alcohol amblyopia (Mackey & Howell, 1994) , a result that suggests a common etiological factor. Rizzo (1995) has hypothesized that the common factor is a deficiency in mitochondrial ATP production. He further hypothesized that the P ganglion cells are particularly susceptible to ATP depletion because of their high firing rate, compared to that of M ganglion cells, aJad to their sustained action potentials. Rizzo (1995) also noted the possible role of vitamin B I2 deficiency as a causative factor in bilateral optic neuropathy. Golnik and Schaible (1994) have described a set of bilateral optic neuropathy patients with normal B12 levels but who were folate deficient. Treatment with folate resulted in improvement of visual acuity in these patients. These authors suggest that a deficiency of B12 or folate results in decreased tetrahydrofolate production, which--in turn---leads to decreased detoxification of formate and a chronic inhibition of mitochondrial cytochrome oxidase.
An epidemic optic neuropathy, with an occasional peripheral neuropathy, affected >40000 Cubans in the early 1990s. Although a few "true" LHON patients were identified, a major etiological role for mitochondrial mutations was not substantiated and the principal causative factors appear to have been insufficient nutrition, heavy use of tobacco, and consumption of home-made rum, possibly contaminated with methanol (Hirano et al., 1994; Johns & Sadun, 1994; Newman et al., 1994) .
Chloramphenicol optic neuropathy
In the 1950s and 1960s, the antibiotic chloramphenicol was used to treat children with cystic fibrosis (Lloyd et al., 1963) . However, it was soon reported that chloramphenicol treatment was associated with the development of an optic neuritis/optic atrophy, the incidence and severity of which was dose-dependent (Cocke et al., 1966; Huang et al., 1966; Harley et al., 1970) . In a presentation that was remarkably similar to that in LHON patients, there was a sudden onset, bilateral loss of central vision with the formation of central scotoma; papilloedema and pallor of the disk were also documented. Furthermore, it was commonly observed that there was an engorgement and tortuosity of the retinal veins with occasional retinal hemorrhage (Harley et al., 1970) . Many of these optic neuritis/optic atrophy ]patients also had an accompanying peripheral neuropathy. In most cases, the vision deficit was corrected by :~topping the chloramphenicol and/or by multi-vitamin treatment including folate and B12. Neuropathological studies of five patients that had undergone long-term chloramphenicol treatment revealed degeneration in the ganglion cell layer, degeneration and demyelination of the optic nerve (particularly in the papillomacular bundle), and gliosis of the nerve fiber layer (Table 3 of Harley et al., 1970) .
The use of the chloramphenicol in cystic fibrosis patients, and the study of the resulting optic neuritis/optic atrophy, were undertaken before it was recognized that this antibiotic is a specific inhibitor of rrtitochondrial protein synthesis. The retrospective interpretation of these results is that systemic application of an inhibitor of mitochondrial protein synthesis produced a selective ophthalmological pathology that was remarkably similar to LHON and one that was phenotypically reversible, at least to some extent, in terms of visual acuity. These results, therefore, provide the strongest and most direct evidence that the ganglion cell layer and optic nerve are exquisitely sensitive to the disruption of rnitochondrial biogenesis.
LHON, GLAUCOMA, AND EXCITOTOXICITY
A comparison of LHON with glaucoma reveals a relationship that merits further study. Electrophysiological and psychophysical tests of early stage glaucoma patients indicate a selective defect in the magnocellular channel that links the retina to the lateral geniculate nucleus (Bodis-Wollner, 1989) . Neuropathological studies confirm this pathway and report a selective degeneration of the M (or large) ganglion cells (Quigley et al., 1988; Wygnanski et al., 1995) .
In a recent review, Schumer and Podos (1994) have proposed that the neurodegeneration in glaucoma proceeds through an excitotoxic "cascade" that involves persistent activation of NMDA receptors in the optic nerve, excessive calcium influx, increased nitric oxide synthesis, and production of oxygen free r~dicals. They develop an impressive argument. It is particularly striking that glutamate, an excitatory neurotransmitter, is more toxic to large ganglion cells, both in tissue culture of ganglion cells and in the intact rat (Dreyer et al., 1994) . Furthermore, glatamate is elevated in the vitreous body of glaucoma patients (Dreyer et al., 1996) . Excitotoxic neuronal death can occur through necrosis or apoptosis, depending upon the experimental conditions [e.g. Gwag et al. (1995)] . To add what may be the final step in the excitotoxic model, Quigley et al. (1995) have concluded that retinal ganglion cell death in experimental glaucoma occurs by apoptosis.
Both glaucoma and LHON (and other optic neuropathies) are similar disorders in that they result in degeneration of the ganglion cell layer and optic nerve. However, LHON and glaucoma clearly differ in their etiologies in which a respiratory chain dysfunction is identified as a major factor in LHON, and in the subpopulation(s) of retinal ganglion cells that are affected. Among the other notable similarities, there are indications in both that the region of the optic nerve as it transverses the lamina cribosa is a particularly vulnerable site [for glaucoma, see Fechtner & Weinreb (1994) and Quigley (1995) ]. In this regard, cupping of the disk in LHON patients has been observed in several studies [e.g. Weiner et al. (1993) and references therein]. There is also evidence that an early event in glaucoma model systems is a defect in axoplasmic transport (Quigley, 1995) .
MODELS FOR LHON AND SOME CONCLUDING THOUGHTS
What do we know about LHON? In some respects, as reviewed here, a great deal. In terms of which cells are dying and why, less so. Rizzo (1995) has hypothesized that LHON is one of a group of optic neuropathies that share an ATP deficiency which results in degeneration of the P ganglion cells. Although an attractive hypothesis, the neuropathology suggests drop-out of both M and P ganglion cells in the central retina [e.g. Kwittken & Barest (1958) ]. Riordan-Eva et al. (1995) have proposed a related but more detailed hypothesis. For example, they argue that the characteristic microangiopathy is a secondary, consequence of events that occur within the inner retina. They then extend the "disk at risk" concept and suggest that the LHON family members who become affected may have congenital crowding of the ganglion cell axons at the disk and in the peripapillary region. Finally, they contend that it is the small diameter nerve fibers in the central retina that degenerate during the acute phase.
There is a lot to commend in the model of RiordanEva, particularly the postulate that subtle anatomical differences in the nerve fiber layer and disk have marked effects on the risk of vision loss. In addition, the structure of the lamina cribosa also appears to be important (Burde, 1993) . One may envisage that the primary LHON mutations produce a respiratory chain defect that, as its most direct effect for pathogenesis, compromises axoplasmic transport, particularly in the lamina cribosa "chokepoint" [cf Hollander et al. (1995) i]. As a consequence of further physiological stress and/or the anatomical features within an individual, local axoplasmic transport slows to a level that precludes normal functioning of the ganglion cells [cf Sadun et al. (1994) ]. There is evidence for individual variation in the density of the trabecular structural elements, a result that may define an important risk factor (Radius & Gonzales, 1981; Quigley, 1995) . The small diameter fibers are the most vulnerable to these noxious factors, but how this vulnerability is determined by the anatomical, metabolic, or neurochemical properties of the inner retina remains an important area for further investigation. A related question is to understand why some fibers are relatively refractory, such as those that control the pupillary response.
It is at the stage of axoplasmic stasis that the biochemical signal for neurodegeneration can be triggered. In the case of the 11 778 primary" mutation, for reasons which are not yet clear, the "commitment to death" is made with only rare exception: the inactive ganglion cells die, possibly through an apoptotic pathway. This latter possibility would seem to be supported by the report that retinal ganglion cells undergo apoptosis in anterior ischemic optic neuropathy (Levin & Louhab, 1996) . In the case of the 14484 primary mutation, the commitment to death is much less strong or less frequent with the consequence that, for prolonged periods of time, the ganglion cells are inactive but still viable. The 3460 primary mutation apparently occupies the middle ground between these two extremes. If the hypothesis of axoplasmic stasis is correct, recovery of vision in 14484 LHON patients might occur as the result of a small amount of neurodegeneration, thus relieving the anatomical block to axoplasmic transpor~t in the viablebut-inactive neurons. Although it is counter-intuitive, perhaps a little neurodegeneration can be a good thing! This suggestion also explains why the pe~ incidence of LHON is in the mid-twenties: starting in the second decade, there is a slow loss of foveal ganglion cells (Gao & Hollyfield, 1992) , thus widening the anatomical chokepoint and commensurately diminishing the risk of vision loss. One possible explanation for the differences among primary LHON mutations, according to the hypothesis under consideration, is that while all of them impair respiratory chain function, they differ in thee production of free radicals at the level of complex I, a key factor in excitotoxicity/apoptosis pathways (Beal. 1995; Cui & Harvey, 1995; Wood & Youle, 1995) . All, or almost all, retinal ganglion cells express NMDA receptors that are involved in synaptic transmission with cone bipolar cells [e.g. Hartveit et al. (1994) ], and it is tempting to invoke an excitotoxic pathway.
In summary, it has been the purpose here to review briefly what we know about LHON, and what we do not know. Molecular genetic diagnosis is on solid ground. Although a complete understanding of the complex etiology is lacking, several likely risk factors have been proposed. We seem to be at the stage where we will start learning more about the cellular and biochemical pathways leading to optic nerve degeneration. This progress will be important because it is from here that preventive or curative pharmacological intervention will come for LHON and, probably, for other optic nerve disorders as well.
